The International Atomic Energy Agency (IAEA) plans to step up and help Iran meet its nuclear medicine and therapy needs, according to a 4 March report in Bloomberg News.
Iran has been dealing with shortages of nuclear medicine radiopharmaceuticals since the U.S. in 2018 reimposed sanctions when President Trump pulled out of an existing agreement designed to curtail Iran's ability to develop nuclear weapons. More recently, the U.S. has threatened new sanctions and more aggressive inspections to ensure Iran's compliance.
IAEA inspectors have repeatedly confirmed that Iran is abiding by the restrictions signed three years ago, according to the article. Yukiya Amano, IAEA's director general, was reported to have said the agency is "willing to help" meet Iran's nuclear medicine and therapy needs during an interview with Bloomberg News. Switzerland and the European Union also reportedly have opened new trade channels to Iran.
China, France, Germany, Russia, and the U.K. are currently meeting at IAEA headquarters in Vienna to discuss the sanctions.
